Search for: "Cooper v. Life Ins Co"
Results 41 - 60
of 68
Sort by Relevance
|
Sort by Date
22 Dec 2010, 11:36 am
Disputes between Blix Street and the Cassidys arose over royalty payments and the Cassidys’ plan for a motion picture about their daughter’s life. [read post]
22 Dec 2010, 11:36 am
Disputes between Blix Street and the Cassidys arose over royalty payments and the Cassidys’ plan for a motion picture about their daughter’s life. [read post]
21 May 2010, 1:26 pm
Woodmen of the World Life Ins. [read post]
9 May 2010, 9:41 am
Life Ins. [read post]
5 Mar 2010, 9:10 pm
Hartford Life Ins. [read post]
27 Feb 2010, 8:03 am
Foremost Life Ins. [read post]
5 Feb 2010, 4:24 am
John Alden Life Ins. [read post]
3 Feb 2010, 4:31 am
Jackson National Life Ins. [read post]
22 Nov 2009, 7:44 am
John Alden Life Ins. [read post]
23 Oct 2009, 10:00 am
Alan Mansfield, for appellants Metropolitan Insurance and Annuity Company and Metropolitan Tower Life Insurance Company. [read post]
22 Jul 2009, 12:18 am
Ins. [read post]
14 Jul 2009, 7:50 pm
Southland Life Ins. [read post]
1 Jul 2009, 12:55 am
Keyes, special counsel at the firm, write: In Continental Casualty Co. v. [read post]
30 May 2009, 6:45 am
Jefferson-Pilot Life Ins. [read post]
16 Mar 2009, 11:45 am
Lexington Ins. [read post]
26 Feb 2009, 12:25 am
Co. v. [read post]
14 Feb 2009, 11:56 am
Part V identifies key unresolved issues in the state courts. [read post]
18 Sep 2008, 10:00 am
Then there is the personal factor: divorce presents a significant life crisis for most of our clients, and we see them at their most vulnerable and most needy. [read post]
27 Jul 2008, 3:27 pm
"8 Cooper Industries, Inc. v. [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by… [read post]